Investigation Report on China's Ustekinumab Market 2021-2025
No. of Pages: 50
Ustekinumab is a monoclonal antibody medication developed by Janssen Pharmaceuticals. It is mainly used to treat psoriasis, Crohn's disease, and ulcerative colitis. Janssen’s Ustekinumab, STELARA
|
21-May-2021
|
2600
|
Investigation Report on the Chinese Cobalt Market 2021-2025
No. of Pages: 60
The industry chain of cobalt mainly includes cobalt ore mining and dressing (upstream), cobalt smelting and processing (midstream) and terminal utilization of cobalt (downstream). In
|
21-May-2021
|
2800
|
Investigation Report on the Chinese Rare Earth Market 2021-2025
No. of Pages: 70
Rare earth elements and metals are widely used in the industry. Rare earths are used to improve the production efficiency of traditional industries such as
|
21-May-2021
|
2800
|
Investigation Report on the Chinese Construction Machinery Industry Market 2021-2025
No. of Pages: 70
The production and export volume of China's construction machinery industry has been ranked first in the world. By the first half of 2021, 11 Chinese
|
21-May-2021
|
2800
|
Investigation Report on China's Funeral Market 2021-2025
No. of Pages: 50
DESCRIPTION
The funeral and interment industry can be divided into four parts from the perspective of service content: funeral services, disposal of remains, cemetery services, and
|
21-May-2021
|
2600
|
Investigation Report on China's Shingles Vaccine Market 2021-2025
No. of Pages: 40
Description
The trade name of Shingles Vaccine is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Recombinant zoster vaccine
|
21-May-2021
|
2600
|
Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025
No. of Pages: 50
Description
Salmeterol/Ticasone is a compound medication used in regular treatment of asthma and chronic obstructive pulmonary disease (COPD). Its original drug was developed by GlaxoSmithKline. In
|
21-May-2021
|
2600
|
Investigation Report on China's Palbociclib Market 2021-2025
No. of Pages: 50
Description
Palbociclib is the world's first selective inhibitor of CDK 4/6 launched by Pfizer. By inhibiting CDK 4/6, Palbociclib restores cell cycle control, thereby blocking tumor
|
21-May-2021
|
2600
|
Investigation Report on China's Infliximab Market 2021-2025
No. of Pages: 50
Description
Infliximab is a human-mouse chimeric IgG1 monoclonal antibody targeting tumor necrosis factor (TNF-α) (composed of human IgG1 constant region and mouse variable region). It is
|
21-May-2021
|
2600
|
Investigation Report on China's Dulaglutide Market 2021-2025
No. of Pages: 50
Description
Dulaglutide is a weekly long-acting GLP-1 receptor agonist developed by Eli Lilly and was approved to enter China in 2019. Dulaglutide is suitable for the
|
21-May-2021
|
2600
|
Investigation Report on China's Aflibercept Market 2021-2025
No. of Pages: 40
Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration (wAMD), and other retinopathy caused by visual impairment. Aflibercept was jointly developed
|
23-Apr-2021
|
2600
|
Investigation Report on China's Human Serum Albumin Market 2021-2025
No. of Pages: 50
Human Serum Albumin (HSA) is made of plasma proteins from human blood, which is mainly used to replace blood volume loss resulting from trauma such
|
23-Apr-2021
|
2600
|
Investigation Report on China's Ibrutinib Market 2021-2025
No. of Pages: 40
Ibrutinib is a BTK inhibitor, mainly used to treat B-cell carcinomas, such as mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib was first
|
23-Apr-2021
|
2600
|
Investigation Report on China's Iodixanol Market 2021-2025
No. of Pages: 50
Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography,
|
23-Apr-2021
|
2600
|
Investigation Report on China's Lenalidomide Market 2021-2025
No. of Pages: 50
Lenalidomide is an oral immunomodulatory drug that is mainly used to treat blood cancers such as multiple myeloma, myelodysplastic syndrome, and lymphoma. Lenalidomide was first
|
23-Apr-2021
|
2600
|
Investigation Report on China's Meropenem Market 2021-2025
No. of Pages: 50
Meropenem is an antibiotic that is used to treat a variety of bacterial infections, including meningitis, pneumonia and so on. Meropenem is jointly developed by
|
23-Apr-2021
|
2600
|
Investigation Report on China's Nivolumab Market 2021-2025
No. of Pages: 50
Nivolumab is a human IgG4 monoclonal antibody that blocks PD-1, mainly used to treat non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, advanced renal
|
23-Apr-2021
|
2600
|
Investigation Report on China's Oseltamivir Market 2021-2025
No. of Pages: 50
Oseltamivir is an antiviral drug used to treat or prevent influenza virus type A and B. Oseltamivir was invented by Gilead Sciences, and Roche purchased
|
23-Apr-2021
|
2600
|
Investigation Report on China's Osimertinib Market 2021-2025
No. of Pages: 50
Osimertinib is a small molecule targeted anti-tumor drug used to treat non-small cell lung cancer (NSCLC). The original drug, TAGRISSO was developed by AstraZeneca. Osimertinib
|
23-Apr-2021
|
2600
|
Investigation Report on China's Rituximab Market 2021-2025
No. of Pages: 50
Rituximab is a monoclonal antibody to target cells that have the CD20 marker on their surface. It is mainly used to treat diseases caused by
|
23-Apr-2021
|
2600
|
